Genomic Landscape of Early-Onset and Familial Latin American Parkinson's Patients.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Waldo Emily, Chaparro-Solano Henry Mauricio, Isayan Mariam, Leal Thiago Peixoto, Duarte-Zambrano Felipe, Inca-Martinez Miguel, Ramchandra Janvi, Rivera Paz Maria, Makarious Mary B, Hernandez Carlos, Gatto Emilia M, Gonzalez Rojas Natalia, Cesarini Martin Emiliano, Santos-Lobato Bruno Lopes, Letro Grace Helena, Orozco Jorge Luis, Munoz Ospina Beatriz, Chana-Cuevas Pedro, Rojas Natalia Andrea, Aguillon David, Muller Valentina, Braga-Neto Pedro, Rodríguez-Violante Mayela, Cervantes-Arriaga Amin, Schuh Artur F S, Cornejo-Olivas Mario, Mejia Rojas Koni, Armas Cintia, Viñuela Ángel, Espinal Martinez Alan Osvaldo, Tumas Vitor, Borges Vanderci, Avila Cesar Luis, Olguin Patricio, Alcauter Sarael, Kauffman Marcelo, Gonzalez-Moron Dolores, Peña Susana Lissette, Mata Ignacio F
Аннотация
OBJECTIVES: Our goal was to perform a variant screening of seven PD-related genes and 21 genes associated with related parkinsonian disorders to identify pathogenic/likely pathogenic variants and variants of uncertain significance within EOPD and family-history-positive individuals within the Latin American Research Consortium on the Genetics of PD (LARGE-PD).
METHODS: We performed short-read whole-genome sequencing on a subset of 263 individuals with EOPD and/or a familial history of PD who had no known pathogenic PD variant in genotyping data.
RESULTS: Of the analyzed individuals, a monogenic burden in primary and secondary PD genes due to pathogenic or likely pathogenic variants for PD was observed in 4.7%, an additional 5.5% had pathogenic or likely pathogenic variants for Gaucher's disease, and 2.7% had known risk variants in GBA1 .
CONCLUSIONS: By expanding the reported spectrum of disease-associated variants in a Latin American population, we identified previously unreported or underrepresented variants that would likely be missed by array-based or targeted screening approaches and contribute to the characterization of EOPD and familial PD in Latin America.